<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ko J</submitter><funding>NIMH NIH HHS</funding><pagination>3244-55</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2771087</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>28(20)</volume><pubmed_abstract>Postsynaptic neuroligins are thought to perform essential functions in synapse validation and synaptic transmission by binding to, and dimerizing, presynaptic alpha- and beta-neurexins. To test this hypothesis, we examined the functional effects of neuroligin-1 mutations that impair only alpha-neurexin binding, block both alpha- and beta-neurexin binding, or abolish neuroligin-1 dimerization. Abolishing alpha-neurexin binding abrogated neuroligin-induced generation of neuronal synapses onto transfected non-neuronal cells in the so-called artificial synapse-formation assay, even though beta-neurexin binding was retained. Thus, in this assay, neuroligin-1 induces apparent synapse formation by binding to presynaptic alpha-neurexins. In transfected neurons, however, neither alpha- nor beta-neu</pubmed_abstract><journal>The EMBO journal</journal><pubmed_title>Neuroligin-1 performs neurexin-dependent and neurexin-independent functions in synapse validation.</pubmed_title><pmcid>PMC2771087</pmcid><funding_grant_id>R37 MH052804</funding_grant_id><pubmed_authors>Boucard AA</pubmed_authors><pubmed_authors>Arac D</pubmed_authors><pubmed_authors>Sudhof TC</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors><pubmed_authors>Ko J</pubmed_authors><pubmed_authors>Brunger AT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neuroligin-1 performs neurexin-dependent and neurexin-independent functions in synapse validation.</name><description>Postsynaptic neuroligins are thought to perform essential functions in synapse validation and synaptic transmission by binding to, and dimerizing, presynaptic alpha- and beta-neurexins. To test this hypothesis, we examined the functional effects of neuroligin-1 mutations that impair only alpha-neurexin binding, block both alpha- and beta-neurexin binding, or abolish neuroligin-1 dimerization. Abolishing alpha-neurexin binding abrogated neuroligin-induced generation of neuronal synapses onto transfected non-neuronal cells in the so-called artificial synapse-formation assay, even though beta-neurexin binding was retained. Thus, in this assay, neuroligin-1 induces apparent synapse formation by binding to presynaptic alpha-neurexins. In transfected neurons, however, neither alpha- nor beta-neu</description><dates><release>2009-01-01T00:00:00Z</release><publication>2009 Oct</publication><modification>2026-03-16T16:56:07.248Z</modification><creation>2025-09-01T03:06:25.586Z</creation></dates><accession>S-EPMC2771087</accession><cross_references><pubmed>19730411</pubmed><doi>10.1038/emboj.2009.249</doi></cross_references></HashMap>